ホーム>>Analytical Standards>>Methohexital (exempt preparation)

Methohexital (exempt preparation) (Synonyms: 5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric Acid,Compound 22451,Compound 25398,Methohexitone)

カタログ番号GC91534

Methohexital (exempt preparation) is an analytical reference standard categorized as a barbiturate.

Products are for research use only. Not for human use. We do not sell to patients.

Methohexital (exempt preparation) 化学構造

Cas No.: 151-83-7

サイズ 価格 在庫数 個数
1 mg
$55.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Methohexital (exempt preparation) is an analytical reference standard categorized as a barbiturate. Methohexital has anticonvulsant activity in mice.[1] It substitutes for cocaine in baboons.[2] Formulations containing methohexital have been used as general anesthetics. Methohexital is regulated as a Schedule IV compound in the United States. Methohexital (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

References:
[1].Lowson, S., Gent, J.P., and Goodchild, C.S.Convulsive thresholds in mice during the recovery phase from anaesthesia induced by propofol, thiopentone, methohexitone and etomidateBr. J. Pharmacol.102(4)879-882(1991).
[2].Griffiths, R.R., Lamb, R.J., Sannerud, C.A., et al.Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboonsPsychopharmacology (Berl.)103(2)154-161(1991).

レビュー

Review for Methohexital (exempt preparation)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Methohexital (exempt preparation)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.